rheumatoid factor

Related by string. * Rheumatoid : rheumatoid arthritis RA . osteoarthritis OA rheumatoid arthritis . multiple sclerosis rheumatoid arthritis . rheumatoid arthritis psoriasis . osteoarthritis rheumatoid arthritis / factoring . factored . factors . Factors . Factor : CERTAIN MARKET FACTORS SUCH . Risk Factors section . heading Risk Factors . Item 1A Risk Factors . X Factor Cher Lloyd * *

Related by context. All words. (Click for frequent words.) 74 CCP antibodies 69 thyroglobulin 69 alanine aminotransferase ALT 68 SGPT 68 elevated ALT 68 HCV antibody 67 estrogen receptor ER 67 seronegative 67 erythrocyte sedimentation rate 66 HER2 overexpression 66 primary aldosteronism 66 CC genotype 66 cTnT 66 albumin excretion rate 66 aminotransferases 66 IgM 65 ERalpha 65 PsA 65 lowest tertile 65 seropositivity 65 alanine aminotransferase 65 T2DM 65 D dimer 65 urine cytology 65 eosinophil count 65 PSA nadir 65 coronary stenosis 65 troponin T 65 colorectal adenoma 65 transaminase elevations 65 bronchoalveolar lavage 65 pT3 65 HBeAg 65 antibody titer 65 albumin excretion 64 eosinophilia 64 serum HBV DNA 64 HER2 expression 64 bronchial hyperresponsiveness 64 serum PSA 64 isoenzyme 64 serum cortisol 64 homozygotes 64 pg ml 64 PCa 64 lymphocytosis 64 myeloperoxidase 64 specific antigen PSA 64 AST ALT 64 TT genotype 64 pmol L 64 β blockers 64 airway hyper responsiveness 64 Ki# 64 epithelial tumors 64 serum ALT 64 thyroid peroxidase 64 highest tertile 64 ADPKD 64 HBsAg 64 serum prostate 64 tryptase 64 inotropic 64 aspartate aminotransferase 64 Leydig cell 64 seminal vesicle invasion 64 tTG 64 rs# [002] 64 â ‰ ¥ 64 tissue transglutaminase 64 serum thyroglobulin 64 #.#ng/ml 64 TNFalpha 64 cagA 64 intact parathyroid hormone 64 lupus anticoagulant 64 leukocytosis 63 leukocyte counts 63 advanced adenomas 63 CIN2 + 63 SNP rs# [001] 63 rs# [004] 63 cTnI 63 airway responsiveness 63 neoplasias 63 elevated LDH 63 pentoxifylline 63 intima media thickness 63 invasive carcinomas 63 cardiac troponin T 63 pT2 63 SGOT 63 exhaled nitric oxide 63 autoantibody 63 elevated transaminases 63 squamous intraepithelial lesions 63 neutrophil count 63 aspartate aminotransferase AST 63 μg ml 63 antigen PSA levels 63 autoimmune thyroid 63 ovarian carcinoma 63 latent celiac disease 63 immunostaining 63 elevated creatinine 63 obstructive coronary artery 63 chlamydial infection 63 LV dysfunction 63 microalbuminuria 63 serum IgE 63 macroalbuminuria 63 IL 1ß 63 serologic 63 P = .# 63 MetS 63 prostate cancer CaP 63 obstructive coronary 63 bioavailable testosterone 63 cardiac troponin 63 HRCT 63 urine albumin 63 albuminuria 63 ERBB2 63 latent tuberculosis infection 63 spirometric 63 arteriography 62 Clusterin 62 liver histology 62 NMIBC 62 lactate dehydrogenase LDH 62 % CI #.#-#.# [007] 62 hormone receptor negative 62 haematologic 62 univariate analysis 62 confidence interval #.#-#.# 62 anti JCV antibodies 62 diabetes mellitus DM 62 microvessel density 62 APOE ε4 62 chloride secretion 62 antiphospholipid antibodies 62 hypothalamic pituitary 62 pCR 62 airway hyperresponsiveness 62 histological subtype 62 subclinical hyperthyroidism 62 hyperparathyroidism 62 serum potassium 62 antinuclear antibody 62 mRNA expression 62 extracapsular extension 62 HLA DR4 62 alpha1 62 BRAF mutation 62 LPS induced 62 Her2/neu 62 serum urate levels 62 IgG antibody 62 biochemical recurrence 62 fasting insulin 62 leukocyte count 62 LV ejection fraction 62 isoprostane 62 HIV HCV coinfected 62 GSTP1 62 % CI #.#-#.# [006] 62 HOMA IR 62 atypical hyperplasia 62 alkaline phosphatase 62 colorectal carcinoma 62 variant allele 62 NRTI resistance 62 hydroxyvitamin D levels 62 autonomic dysfunction 62 interleukin IL -6 62 subclinical atherosclerosis 62 Gram stain 62 rs# [003] 62 preoperative PSA 62 serum ferritin 62 HBeAg negative patients 62 genotypic resistance 62 multivariate Cox 62 UGT#A# * 62 Kinoid 62 progesterone receptor PR 62 cytokeratin 62 HBeAg negative 62 carotid IMT 62 diastolic hypertension 62 breast carcinoma 62 histologically proven 62 hepatocellular carcinomas 62 lactate dehydrogenase 62 MTHFR 62 neovascular 62 SHBG levels 62 node metastases 62 ELISPOT 62 serum lipid levels 62 gastric adenocarcinoma 62 K ras mutations 62 advanced adenoma 62 Prostate specific antigen 62 hepatic enzyme 62 Multivariate analysis 62 DFMO 62 euthyroid 61 neutrophil counts 61 hemodilution 61 TRAF1 C5 61 promoter methylation 61 TEAEs 61 CIN3 61 GG genotype 61 PKC inhibitors 61 choroidal neovascularization 61 left ventricular hypertrophy 61 -#.# ± [002] 61 C Reactive Protein 61 carcinoembryonic antigen 61 hematopoietic cancers 61 transferrin saturation 61 ALT normalization 61 parkinsonism 61 induced sputum 61 GH deficiency 61 thyroid stimulating hormone 61 confidence intervals CIs 61 impaired glucose metabolism 61 adrenalectomy 61 pulmonary artery pressure 61 carotid stenosis 61 mineralocorticoid 61 locoregional recurrence 61 leukemia CML 61 MGUS 61 neoplasm 61 thyroid carcinoma 61 μmol L 61 heterozygotes 61 histologically 61 Subgroup analyzes 61 CP CPPS 61 protein excretion 61 thyroid stimulating hormone TSH 61 immunoreactivity 61 S. aureus isolates 61 mammographically 61 affective psychosis 61 pg mL 61 TOP2A 61 alkaline phosphatase ALP 61 nodal metastasis 61 systolic dysfunction 61 FDG uptake 61 paricalcitol 61 idiopathic PAH 61 onset diabetes mellitus 61 tHcy 61 serum BDNF 61 prolonged QT interval 61 tPSA 61 hemoglobin Hb 61 gene polymorphisms 61 mIU L 61 lymphopenia 61 SLNB 61 serous ovarian cancer 61 microsatellite instability 61 serum IGF 61 rs# [001] 61 posttransplant 61 μg dL 61 bone scintigraphy 61 IL#B 61 comorbid anxiety 61 nitrotyrosine 61 β blocker 61 Hashimoto thyroiditis 61 glomerular filtration 61 atrophic gastritis 61 angiographically 61 prostate cancer PCa 61 % CI #.#-#.# [003] 61 nanomolar 61 lymph node metastasis 61 histopathologic examination 61 extrapyramidal symptoms 61 aminotransferase levels 61 IgA 61 ASCUS 61 thyrotropin 61 grade cervical intraepithelial 61 gastric carcinoma 61 normal karyotype 61 lymphocytic 61 plasma renin activity 61 multivariate analyzes 61 F FDG PET 61 transaminases 61 coronary calcification 61 elevated triglyceride levels 61 rebleeding 61 pretest probability 61 CK MB 61 nonalcoholic steatohepatitis NASH 61 ABCB1 61 nephrotoxicity 61 colorectal neoplasms 61 cystatin C 61 APOE e4 61 inducible nitric oxide synthase 61 thickness IMT 61 MMSE score 60 osteopenic 60 acetabular dysplasia 60 elevated CRP 60 Immunohistochemical staining 60 Estrogen receptor 60 imatinib therapy 60 aminotransferase 60 TIMP 60 clinicopathological features 60 hamartomas 60 bronchial epithelial cells 60 isolated systolic hypertension 60 % Confidence Interval 60 #q# deletion 60 subthreshold 60 rCBF 60 cytogenetic abnormalities 60 baseline LDH 60 Inhibin B 60 BCR ABL mutations 60 nmol liter 60 elevated serum creatinine 60 HER2 amplification 60 HLA A2 60 glomerular filtration rate 60 p = .# [002] 60 hypophosphatemia 60 ventricular tachyarrhythmia 60 fructose intolerance 60 allelic variants 60 bronchoalveolar 60 malignant nodules 60 neoplastic 60 femoral neck BMD 60 natriuretic peptides 60 multivariable analysis 60 TIMP 1 60 seropositive 60 DAS# [002] 60 lymphadenopathy 60 adenomatous polyps 60 basal cell nevus syndrome 60 thyrotropin levels 60 univariate 60 Cystatin C 60 thyrotoxicosis 60 depressive symptomatology 60 serum homocysteine 60 proband 60 pulmonary arterial 60 DAS# CRP 60 C. trachomatis 60 caspofungin 60 lymphovascular invasion 60 micronuclei 60 ritonavir boosted 60 serum PTH 60 5alpha reductase 60 ACTH 60 advanced neoplasia 60 glycosylated hemoglobin HbA1c 60 distant metastasis 60 PON1 60 hyperhomocysteinemia 60 hepatic enzymes 60 mucinous 60 EBV infection 60 HLA B# 60 HGPIN 60 glycosylated hemoglobin 60 carotid plaques 60 subclinical 60 SCr 60 deletion 5q 60 HBeAg seroconversion 60 hypercalciuria 60 CTNNB1 60 mL/min/#.# m2 60 fasting triglycerides 60 prostate abnormalities 60 abdominal adiposity 60 multivariate adjustment 60 ALT AST 60 atypical ductal hyperplasia 60 scintigraphic 60 demyelinating 60 immunochemical 60 leukotriene 60 tumoral 60 QT intervals 60 QTc prolongation 60 radiotherapy RT 60 postoperative AF 60 Depressive symptoms 60 BRAF V#E mutation 60 AhR 60 metastatic malignant 60 IgM antibodies 60 Sjögren syndrome 60 anemia hemoglobin 60 serum phosphate 60 eNO 60 inflammatory biomarkers 60 GSTT1 60 ALT elevations 60 ertapenem 60 HLA DRB1 60 fasting plasma 60 autoantibodies 60 esophagitis 60 nodal metastases 60 histologically confirmed 60 SSc 60 neuritic 60 apolipoprotein B 60 SE alleles 60 MADRS score 60 carotid intima media 60 prognostic significance 60 HLA DRB1 * 60 ejection fractions 60 mutated K ras 60 radical prostatectomy RP 60 plasma folate 60 dysuria 60 adenoma 60 coagulase negative staphylococci 60 SUVmax 60 gene polymorphism 60 glycated hemoglobin levels 60 antithyroid 60 CVD mortality 60 guaiac 60 GFAP 60 CTEPH 60 airflow obstruction 60 CI #.#-#.# [001] 60 apolipoproteins 60 mucosal inflammation 60 glutamic acid decarboxylase 60 polyarticular 60 HBeAg positive patients 60 CI -#.# 60 hyperresponsiveness 60 prognostic factor 60 hyperalgesia 60 pheochromocytoma 60 SNP rs# [002] 60 NNRTI resistance 60 serum HCV RNA 60 hypertensives 60 colorectal carcinomas 60 tipranavir r 60 elevated IOP 60 plasma leptin 60 dose dependently 59 metaplasia 59 colorectal neoplasia 59 HAAH 59 adenoma recurrence 59 C reactive protein 59 endometrial thickness 59 echocardiographic parameters 59 biochemical relapse 59 serum albumin 59 NAbs 59 estimated glomerular filtration 59 flutamide 59 CagA 59 hypogonadotropic hypogonadism 59 PHPT 59 serum creatinine levels 59 glycated hemoglobin HbA1c 59 cervical intraepithelial neoplasia 59 sweat chloride 59 T2 lesions 59 #OHD 59 nasal polyposis 59 sensory neuropathy 59 cytologic 59 PTPN# 59 hyperintensities 59 IgA deficiency 59 Helicobacter pylori infection 59 giant cell arteritis 59 prostate carcinoma 59 cytopenias 59 TNF receptor 59 mL/min/#.# m 2 59 proteinuria 59 dehydroepiandrosterone sulfate 59 aortic regurgitation 59 tuberculin skin testing 59 NYHA functional class 59 chlamydial 59 antigen PSA 59 arterial oxygen saturation 59 serum bicarbonate 59 PCWP 59 undetectable viral 59 homocysteine concentrations 59 nadolol 59 penetrance 59 leucopenia 59 etiologic 59 estrogen receptor progesterone receptor 59 cervicitis 59 Primary endpoints 59 chronic eosinophilic leukemia 59 peripheral blood mononuclear 59 creatine kinase 59 hsCRP 59 progesterone receptor negative 59 androgen deficiency 59 HIV uninfected 59 collagenous colitis 59 CD# CD# 59 lymphocyte count 59 prognostic indicator 59 59 Adenomas 59 nonischemic 59 myelodysplastic myeloproliferative diseases 59 histopathological 59 poor metabolizers 59 log# copies mL 59 plasma homocysteine 59 REYATAZ r arm 59 allostatic load 59 thymoma 59 intravascular hemolysis 59 comorbid depression 59 paragangliomas 59 hypericin 59 antiandrogens 59 viral titers 59 platelet reactivity 59 intestinal metaplasia 59 histologic subtype 59 Asymptomatic 59 PSADT 59 ALT flares 59 laboratory abnormalities 59 grade squamous intraepithelial 59 arterial calcification 59 BMI z 59 subclinical hypothyroidism 59 undetectable HBV DNA 59 HBeAg positive 59 GABRA2 59 serum antibodies 59 HLA DR2 59 subscale scores 59 granulomatous 59 IFN γ 59 atopic 59 invasive ductal 59 serum testosterone levels 59 HER2 positive cancers 59 peritoneal fluid 59 OGTT 59 EpCAM 59 polyposis 59 trans retinoic acid 59 seropositive patients 59 endothelial activation 59 autoantibody levels 59 μg liter 59 vWF 59 PaO 2 59 urinary excretion 59 Hormone receptor 59 chest radiography 59 neurocognitive function 59 RASSF1A 59 epithelial ovarian cancer 59 serum calcium 59 lipid elevations 59 chromosomal aberrations 59 enthesitis 59 erythropoietic 59 prognostic biomarker 59 Upregulation 59 Histologic 59 urothelial carcinoma 59 sensitivity specificity 59 ERK activation 59 fasting glucose levels 59 Multivariate analysis showed 59 cell adhesion molecule 59 Haptoglobin 59 mammographic density 59 completely resected 59 neuroregenerative 59 serum retinol 59 duplex ultrasonography 59 underwent coronary angiography 59 moderate renal impairment 59 TNF α 59 FluCAM arm 59 #ng/ml 59 catechol O methyltransferase 59 mitochondrial toxicity 59 obstructive CAD 59 mucosal lesions 59 corticosteroid dose 59 #OHD levels 59 hypercoagulable 59 varices 59 UGT#A# 59 adrenocortical 59 E selectin 59 serum selenium 59 subsyndromal 59 paraneoplastic 59 serum creatinine 59 HDL2 59 functional polymorphism 59 APOE genotype 59 hereditary hemochromatosis 59 cranial irradiation 59 ELISA enzyme 59 hypovitaminosis D 59 Ph + 59 intensive statin therapy 59 pleural fluid 59 neurologic complications 59 lavage fluid 59 Relapsing Remitting Multiple Sclerosis 58 renal dysfunction 58 IFN beta 58 H pylori 58 mmHg diastolic 58 non squamous histology 58 ELISpot 58 DRD2 58 epididymitis 58 choroidal neovascularization CNV 58 antibody titers 58 DMARD 58 Lp PLA 2 58 ADAS Cog 58 HRQOL 58 immunoreactive 58 ß = 58 RQ PCR 58 hepatorenal syndrome 58 shorter telomere length 58 concomitant medications 58 #beta 58 tuberculin skin test 58 serum triglycerides 58 abnormal lipid 58 bronchoalveolar lavage BAL 58 perfusion abnormalities 58 Prostate Specific Antigen 58 serum vitamin D 58 Hurthle cell 58 HNSCC 58 serum CRP 58 CDKN2A 58 x ULN 58 clusterin 58 juvenile idiopathic arthritis JIA 58 immunopathology 58 CIN3 + 58 p# antigen 58 hyperplastic 58 ovarian malignancy 58 spine BMD 58 immunohistochemical analysis 58 serum testosterone 58 urinary N telopeptide 58 recurrent UTI 58 p = #.# [003] 58 hip BMD 58 EpCAM expression 58 recurrent VTE 58 immunocompetent 58 serum urate 58 denervation 58 Plasma concentrations 58 noncarriers 58 univariate analyzes 58 Viral load 58 lipid parameters 58 nondiabetic patients 58 troponins 58 cTnT levels 58 confidence interval CI 58 psychiatric comorbidity 58 #q# deletion syndrome 58 clinicopathological 58 elevated triglycerides 58 androgen suppression 58 oral antidiabetic medication 58 breast carcinomas 58 CD# expression [002] 58 paroxysmal AF 58 endometrial carcinoma 58 diabetic kidney 58 inflammatory rheumatic 58 carcinomatosis 58 parasitaemia 58 systolic hypertension 58 multivariable adjusted 58 monocytic 58 gonococcal 58 digital rectal examination 58 Prostate Specific Antigen PSA 58 elevated fasting glucose 58 lipid abnormalities 58 elevated homocysteine 58 IL6 58 isotypes 58 artery stenosis 58 ^ sup #m 58 radiographic findings 58 mesenteric 58 c reactive protein 58 BRAF mutations 58 axillary lymph node 58 GBA mutations 58 mm Hg systolic 58 osteosarcomas 58 plasma creatinine 58 CD#c 58 % CI #.#-#.# [008] 58 brain natriuretic peptide 58 triiodothyronine 58 immunochemical fecal occult 58 DAS# scores 58 sonographically 58 IFN α 58 atherogenic dyslipidemia 58 genital ulcers 58 spondyloarthritis 58 renal cell carcinomas 58 HLA DR 58 endometrial hyperplasia 58 glycated hemoglobin 58 WOMAC pain 58 urolithiasis 58 bacteriuria 58 BRAF V#E 58 vimentin 58 chemosensitivity 58 TP# mutations 58 noncalcified 58 B7 H3 58 vasomotor 58 metastatic lymph nodes 58 neutropaenia 58 basal cell carcinoma BCC 58 ε4 58 MLH1 58 Chlamydia pneumoniae 58 p = NS 58 intima media thickness IMT 58 K#R [002] 58 Univariate analysis 58 elevated LDL cholesterol 58 nonobese 58 amnestic MCI 58 clinico pathological 58 abacavir lamivudine 58 EQ 5D 58 overt nephropathy 58 left ventricular diastolic 58 perioperatively 58 leiomyomas 58 CYP#A# [002] 58 ANCA associated 58 tumorigenicity 58 serum concentrations 58 follicle stimulating hormone FSH 58 transrectal ultrasound guided 58 hematologic toxicity 58 folate concentrations 58 T#I [002] 58 steroidogenic 58 immunohistochemical 58 hematologic abnormalities 58 Scale PANSS 58 esophageal carcinoma 58 serum TSH 58 clinically meaningful reductions 58 metabolite concentrations 58 GABHS 58 ERCC1 58 mycophenolate mofetil 58 apo B 58 pulmonary infiltrates 58 apolipoprotein A1 58 essential thrombocythemia 58 hematological parameters 58 SIBO 58 neurologic symptoms 58 dorsal root ganglion 58 parkinsonian 58 achieved ACR# 58 hepatocellular 58 human chorionic gonadotropin hCG 58 EGFR mutation positive 58 dyssynchrony 58 methacholine challenge 58 CD# expression [001] 58 relapsed MM 58 thrombocytosis 58 #mmHg [001] 58 anemia neutropenia 58 #.#/#.# mm Hg [003] 58 mU liter 58 myopathy rhabdomyolysis 58 interobserver 58 Negative Symptoms 58 carotid artery thickness 58 sputum smear 58 immunofluorescence 58 familial ALS 58 posttreatment 58 ACh 58 PTEN mutations 58 serum estradiol 58 polyp recurrence 58 mIU ml 58 pulmonary vascular 58 intracranial hemorrhage ICH 58 interleukin IL -# 58 neurocognitive impairment 58 fasting plasma glucose 58 p tau 58 LVNC 58 serum calcium levels 58 anti HBs 58 leukemia AML 58 bronchoalveolar lavage fluid 58 variant alleles 58 lipoprotein Lp 58 lymphoproliferative disorders 58 Apolipoprotein B 58 HbA 1c 58 serum triglyceride 58 enteroviral 58 HbA1C 58 fluoroquinolone resistance 58 K#N 58 missense mutations 58 KIF6 gene 58 MBq 58 BLLs 58 Leukemias 58 fibrin deposition 58 T SPOT.TB 58 plasma pharmacokinetics 58 virologic breakthrough 58 -#.# log# 58 anti HBc 58 nonmalignant 58 recurrent DVT 58 Squamous 58 stratifying patients 58 COL#A# 58 total thyroidectomy 58 salivary flow 58 extensive metabolizers 58 aminotransferase ALT 58 apolipoprotein E gene 58 HBV DNA 58 μg L 58 uM 58 arteriolar 58 ATACAND 58 paresthesias 58 regression coefficient 58 perimenopausal women 58 hypereosinophilic syndrome 58 sitosterol 58 squamous cell carcinoma SCC 58 creatine kinase MB 58 metachronous 58 infarcts 58 LRP5 58 KRAS mutations 58 hyperintensity 58 pulmonary capillary wedge 58 GSTM1 58 ductal cancer 58 nonmelanoma skin cancers 58 PSA kinetics 58 Elevated serum 58 papillary thyroid carcinoma 58 COHb 58 testicular tumors 58 semiquantitative 58 tumor necrosis 58 endocrine therapies 58 VEGF expression 58 atopy 58 ^ Tc 58 colorectal adenocarcinoma 58 pelvic lymphadenectomy 57 BENICAR HCT 57 plasma uric acid 57 MSMB 57 irbesartan 57 sCJD 57 Immunohistochemical analysis 57 soluble CD# ligand 57 HepG2 cells 57 angiotensin converting enzyme 57 Nonspecific 57 bFGF 57 fructosamine 57 intrahepatic 57 serum parathyroid hormone 57 CsA 57 cervical lymph nodes 57 BCG vaccinated 57 serotonin norepinephrine 57 XIENCE V PROMUS Stent 57 pulmonary metastases 57 erythema nodosum 57 reticulocytes 57 Prognostic significance 57 extrapyramidal side 57 BRCA2 mutation carriers 57 E. faecalis 57 DQB1 * 57 virological response 57 CIN2 57 polyarticular JIA 57 mU L 57 interobserver agreement 57 tumor lysis syndrome 57 induce orthostatic hypotension 57 Neutrophil 57 Hcy 57 renal insufficiency 57 pathologic diagnosis 57 kidney allograft 57 covariate 57 adenylate cyclase 57 psoriatic arthritis PsA 57 akinesia 57 elastase 57 CD4 + CD# 57 biochemical abnormalities 57 presymptomatic 57 precancerous cervical 57 mCi 57 achieved statistical significance 57 haematological 57 reflux esophagitis 57 baroreceptor 57 BRCA1 mutation carriers 57 ABL1 57 LVEF 57 nonvertebral fractures 57 transcranial Doppler ultrasound 57 Serum creatinine 57 obstructive lung 57 IgA antibodies 57 vasopressor 57 germline mutations 57 S aureus 57 ERK signaling 57 hepatic lipase 57 somatostatin receptor 57 fluvastatin 57 SELENA SLEDAI 57 chest radiographs 57 gastroduodenal 57 null mice 57 NPM1 mutation 57 #F FDG 57 steroidogenesis 57 malondialdehyde 57 JAK2 V#F 57 PAOD 57 5q 57 nerve conduction velocity NCV 57 functional gastrointestinal disorders 57 MRSA isolates

Back to home page